SAM
ACHN

Sectoral Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Sectoral Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-98,400
Closed -$872K – 96
2015
Q2 		$872K Sell
98,400
-3,092,172
-97% -$29.2M 0.04% 70
2015
Q1 		$31.5M Buy
3,190,572
+816,762
+34% +$10.2M 1.19% 28
2014
Q4 		$29.1M Buy
+2,373,810
New +$29M 1.3% 29
2013
Q4 		– Sell
-384,300
Closed -$1.16M – 61
2013
Q3 		$1.16M Sell
384,300
-1,130,400
-75% -$7.75M 0.06% 54
2013
Q2 		$12.4M Buy
+1,514,700
New +$11.6M 0.37% 48

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sectoral Asset Management's ACHN Position: Q3 2015 in Review

Sectoral Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q3 2015, closing a stake of 98,400 shares — an estimated $872K sold.

Sectoral Asset Management first reported a position in ACHN in Q2 2013 and held it in 5 quarters. The position peaked at $31.5M in Q1 2015. 141 funds tracked by Wall St. Rank hold ACHN as of Q3 2015.

  • Sectoral Asset Management reported no remaining Achillion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Sectoral Asset Management sold 98,400 Achillion Pharmaceuticals shares in Q3 2015, an estimated $872K.
  • Sectoral Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Sectoral Asset Management's Achillion Pharmaceuticals position peaked at $31.5M in Q1 2015.
  • 141 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2015.

Based on Sectoral Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.